News

Filter

Current filters:

PharmaceuticalPricing

1 to 9 of 1096 results

Slow growth forecast for Germany’s pharma market

27-03-2015

While Germany is the leading pharmaceutical market in Europe, valued at $58.6 billion in 2014, the sector…

GermanyMarkets & MarketingPharmaceuticalPricingRegulation

Transparency and cooperation help to reduce high prices for new medicines, WHO study shows

26-03-2015

As the number of new medicines introduced in Europe rises, governments are finding it increasingly difficult…

EuropeHealthcarePharmaceuticalPricing

GSK and UK Department of Health in negotiations over Bexsero pricing

GSK and UK Department of Health in negotiations over Bexsero pricing

23-03-2015

UK pharma major GlaxoSmithKline has said it is committed to reaching a conclusion with the UK Department…

BexseroGSKPharmaceuticalPricingUKVaccines

Survey of hydrocodone patients shows schedule changes negatively impact treatment

Survey of hydrocodone patients shows schedule changes negatively impact treatment

20-03-2015

A survey of pain patients to assess the effects of rescheduling hydrocodone has shown that it negatively…

AnalgesiahydrocodoneMarkets & MarketingPharmaceuticalPricingSocial IssuesUSA

Cyprus in danger of medicinal products being withdrawn

Cyprus in danger of medicinal products being withdrawn

17-03-2015

The Cyprus Association of Research and Development Pharmaceutical Companies (KEFEA) is concerned about…

EuropePharmaceuticalPoliticsPricing

Pharma must look to other industries for models of managing high cost of new drugs

Pharma must look to other industries for models of managing high cost of new drugs

13-03-2015

New financing approaches are required in order to account for the emerging extremely expensive drugs…

GileadPharmaceuticalPricingRAND CorporationSovaldi

NICE recommends GSK’s Arzerra for chronic lymphocytic leukemia

NICE recommends GSK’s Arzerra for chronic lymphocytic leukemia

11-03-2015

Confirming an earlier preliminary guidance, medicines cost watchdog for England, the National Institute…

ArzerraGlaxoSmithKlineOncologyPharmaceuticalPricingRegulationUK

NICE gives go ahead for Xolair to treat potentially disabling skin condition

NICE gives go ahead for Xolair to treat potentially disabling skin condition

11-03-2015

The medicines cost watchdog the National Institute of Health and Care Excellence (NICE) has recommended…

DermatologicalsNovartisPharmaceuticalPricingRegulationUKXolair

1 to 9 of 1096 results

Back to top